Abstract
Overall, the success of developing vaccines against acute diseases in the 20th century has laid the groundwork for vaccine development for chronic diseases in the 21st century. It is clear that we are still identifying the appropriate immunogens for inclusion in vaccines for chronic diseases and once identified our progress in enhancing the immune response is crucial for controlling these conditions either as prophylactic or therapeutic vaccines. We now enter a second 'golden age' of vaccinology in the enhanced understanding of common diseases, vaccine development against chronic noninfectious diseases, and in better integrating advances in biology, genomics, immunology, molecular biology, and virology.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 305-307 |
| Number of pages | 3 |
| Journal | Current Opinion in Immunology |
| Volume | 21 |
| Issue number | 3 |
| DOIs | |
| State | Published - Jun 2009 |
Fingerprint
ASJC Scopus subject areas
- Immunology and Allergy
- Immunology
Cite this
The Old and the New : successful vaccines of the 20th century and approaches to making vaccines for the important diseases of the 21st century. / Poland, Gregory; Barrett, Alan.
In: Current Opinion in Immunology, Vol. 21, No. 3, 06.2009, p. 305-307.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - The Old and the New
T2 - successful vaccines of the 20th century and approaches to making vaccines for the important diseases of the 21st century
AU - Poland, Gregory
AU - Barrett, Alan
PY - 2009/6
Y1 - 2009/6
N2 - Overall, the success of developing vaccines against acute diseases in the 20th century has laid the groundwork for vaccine development for chronic diseases in the 21st century. It is clear that we are still identifying the appropriate immunogens for inclusion in vaccines for chronic diseases and once identified our progress in enhancing the immune response is crucial for controlling these conditions either as prophylactic or therapeutic vaccines. We now enter a second 'golden age' of vaccinology in the enhanced understanding of common diseases, vaccine development against chronic noninfectious diseases, and in better integrating advances in biology, genomics, immunology, molecular biology, and virology.
AB - Overall, the success of developing vaccines against acute diseases in the 20th century has laid the groundwork for vaccine development for chronic diseases in the 21st century. It is clear that we are still identifying the appropriate immunogens for inclusion in vaccines for chronic diseases and once identified our progress in enhancing the immune response is crucial for controlling these conditions either as prophylactic or therapeutic vaccines. We now enter a second 'golden age' of vaccinology in the enhanced understanding of common diseases, vaccine development against chronic noninfectious diseases, and in better integrating advances in biology, genomics, immunology, molecular biology, and virology.
UR - http://www.scopus.com/inward/record.url?scp=67049145543&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=67049145543&partnerID=8YFLogxK
U2 - 10.1016/j.coi.2009.05.014
DO - 10.1016/j.coi.2009.05.014
M3 - Article
C2 - 19500965
AN - SCOPUS:67049145543
VL - 21
SP - 305
EP - 307
JO - Current Opinion in Immunology
JF - Current Opinion in Immunology
SN - 0952-7915
IS - 3
ER -